ArticleJACC. Case reports2026
Complex Dissected Subclavian Artery Aneurysm Repair for a Patient With Marfan Syndrome.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMarfan syndrome is a connective tissue disorder associated with progressive vascular complications, particularly aortic and great vessel aneurysms, which present major management challenges. CASE SUMMARY: A 56-year-old woman with a history of 4 prior aortic operations underwent repair of large coronary button aneurysms. Her recovery was uneventful, but 2 months later she developed a right subclavian artery dissection with rapid aneurysmal degeneration. After a period of brief surveillance, a multidisciplinary team performed a complex repair with debranching and bypass of the right common carotid and subclavian arteries along with vertebral artery transposition. DISCUSSION: MFS patients may experience rapid and unpredictable vascular progression. Vigilant follow-up, individualized surgical planning, and multidisciplinary collaboration are essential for optimal outcomes. TAKE-HOME MESSAGE: Marfan patients require close surveillance and proactive, team-based strategies to address evolving vascular complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.